UB Paderborn / Katalog / Suche / in CDI

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

The lancet oncology, 2018-06, Vol.19 (6), p.768-784

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma

Journal of clinical oncology, 2021-03, Vol.39 (7), p.807-821

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort

Journal of clinical oncology, 2020-06, Vol.38 (18), p.2028-2040

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221)

Journal of clinical oncology, 2020-01, Vol.38 (3), p.223-231

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy

Pediatric blood & cancer, 2016-09, Vol.63 (9), p.1527-1534

2016

Link zum Volltext

Verfügbarkeit prüfen

M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas

BMC cancer, 2018-05, Vol.18 (1), p.535-535, Article 535

2018

Link zum Volltext

Verfügbarkeit prüfen

Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4961-4968

2010

Link zum Volltext

Verfügbarkeit prüfen

New Approaches in Targeted Therapy for Medulloblastoma in Children

Anticancer research, 2021-04, Vol.41 (4), p.1715-1726

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood

Scientific reports, 2020-06, Vol.10 (1), p.9371-7, Article 9371

2020

Link zum Volltext

Verfügbarkeit prüfen

Nomograms for predicting the overall survival of patients with cerebellar glioma: an analysis of the surveillance epidemiology and end results (SEER) database

Scientific reports, 2021-09, Vol.11 (1), p.19348-19348, Article 19348

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival

Neuro-oncology (Charlottesville, Va.), 2017-09, Vol.19 (9), p.1217-1227

2017

Link zum Volltext

Verfügbarkeit prüfen

Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour

European journal of cancer (1990), 2017-05, Vol.76, p.84-92

2017

Link zum Volltext

Verfügbarkeit prüfen

Basal Suppression of the Sonic Hedgehog Pathway by the G-Protein-Coupled Receptor Gpr161 Restricts Medulloblastoma Pathogenesis

Cell reports (Cambridge), 2018-01, Vol.22 (5), p.1169-1184

2018

Link zum Volltext

Verfügbarkeit prüfen

Medulloblastoma in childhood: new biological advances

Lancet neurology, 2007-12, Vol.6 (12), p.1073-1085

2007

Link zum Volltext

Verfügbarkeit prüfen

Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study

European journal of cancer (1990), 2013-03, Vol.49 (4), p.893-903

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1627-1636

2009

Link zum Volltext

Verfügbarkeit prüfen

Proton Radiation Therapy for Pediatric Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumors: Outcomes for Very Young Children Treated With Upfront Chemotherapy

International journal of radiation oncology, biology, physics, 2013-09, Vol.87 (1), p.120-126

2013

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma

Oncotarget, 2014-05, Vol.5 (9), p.2355-2371

2014

Link zum Volltext

Verfügbarkeit prüfen

Gamma Knife Radiosurgery for Cerebellopontine Angle Meningiomas: A Multicenter Study

Neurosurgery, 2014-10, Vol.75 (4), p.398-408

2014

Link zum Volltext

Verfügbarkeit prüfen

Survival difference between brainstem and cerebellum medulloblastoma: the surveillance, epidemiology, and end results-based study

Medicine (Baltimore), 2020-10, Vol.99 (41), p.e22366-e22366

2020

Link zum Volltext

Verfügbarkeit prüfen

Shh Signaling Protects Atoh1 from Degradation Mediated by the E3 Ubiquitin Ligase Huwe1 in Neural Precursors

Developmental cell, 2014-06, Vol.29 (6), p.649-661

2014

Link zum Volltext

Verfügbarkeit prüfen

A Prognostic Methylation-Driven Two-Gene Signature in Medulloblastoma

Journal of molecular neuroscience, 2024-04, Vol.74 (2), p.47, Article 47

2024

Link zum Volltext

Verfügbarkeit prüfen

Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols

Pediatric Blood & Cancer, 2008-06, Vol.50 (6), p.1169-1175

2008

Link zum Volltext

Verfügbarkeit prüfen

Metastatic medulloblastoma in adults: Outcome of patients treated according to the HIT2000 protocol

European journal of cancer (1990), 2015-11, Vol.51 (16), p.2434-2443

2015

Link zum Volltext

Verfügbarkeit prüfen

Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study

Journal of hematology and oncology, 2024-04, Vol.17 (1), p.26-26, Article 26

2024

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma

Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort

Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221)

Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy

M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas

Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis

New Approaches in Targeted Therapy for Medulloblastoma in Children

Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood

Nomograms for predicting the overall survival of patients with cerebellar glioma: an analysis of the surveillance epidemiology and end results (SEER) database

The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival

Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour

Basal Suppression of the Sonic Hedgehog Pathway by the G-Protein-Coupled Receptor Gpr161 Restricts Medulloblastoma Pathogenesis

Medulloblastoma in childhood: new biological advances

Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study

Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci

Proton Radiation Therapy for Pediatric Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumors: Outcomes for Very Young Children Treated With Upfront Chemotherapy

Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma

Gamma Knife Radiosurgery for Cerebellopontine Angle Meningiomas: A Multicenter Study

Survival difference between brainstem and cerebellum medulloblastoma: the surveillance, epidemiology, and end results-based study

Shh Signaling Protects Atoh1 from Degradation Mediated by the E3 Ubiquitin Ligase Huwe1 in Neural Precursors

A Prognostic Methylation-Driven Two-Gene Signature in Medulloblastoma

Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols

Metastatic medulloblastoma in adults: Outcome of patients treated according to the HIT2000 protocol

Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study

Aktive Filter

Suchergebnisse filtern